Xolair 150 MG/ML autoinjectorml
Ended Awarded
- Contract number
- SPE2DB25FCNAW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,137
Award facts
- Contract value 100% obligated
- $5,136.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml auto-injectors. Valued at $5,136.66 with a firm fixed-price structure, this delivery order was issued on September 22, 2025, with an ultimate completion date of October 14, 2025. The contract carries no set-aside designation, and performance will occur at the vendor's Park Ridge facility. This award represents a discrete delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026.
DMS Pharmaceutical Group leverages its status as a woman-owned small business to supply a comprehensive range of pharmaceutical products to federal healthcare systems, with a particular focus on supporting Department of Defense medical facilities nationwide. The company's portfolio includes prescription medications, biologics, over-the-counter products, and specialized pharmaceutical items such as auto-injectors and injectable medications. This delivery order for Xolair—a biologic used in allergy and asthma treatment—exemplifies the vendor's role as a critical pharmaceutical supplier within the federal supply chain, delivering essential medications directly to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FCNAW?
SPE2DB25FCNAW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FCNAW worth?
The government has obligated $5,137 on SPE2DB25FCNAW.
Is contract SPE2DB25FCNAW an order under another contract?
Yes. SPE2DB25FCNAW is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCNAW competed?
The extent of competition for SPE2DB25FCNAW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award